Report Detail
Global Restriction Endonucleases Market Growth 2019-2024
- RnM2983018 |
- 19 February, 2019 |
- Global |
- 136 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly classified into four types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another.
Till date more than 10,000 bacteria are screened for the presence of restriction enzymes and currently there are more than 2,500 restriction enzymes have been discovered along with over 250 distinct specificities in sequences. These enzymes are used in conventional cloning, deciphering epigenetic modifications, construction of DNA libraries and in vivo gene editing. The end users mainly are Academic & Research Institutes, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology companies.
The Restriction Endonuclease industry is relatively concentrated, and the players mainly come from North America and Western Europe. In the world wide, major manufactures mainly are New England Biolabs, Thermo Fisher Scientific, Takara Bio, Illumina, Agilent Technologies, Roche, GE Healthcare, Promega Corporation, Qiagen, Jena Biosciences and etc.
According to this study, over the next five years the Restriction Endonucleases market will register a 5.6% CAGR in terms of revenue, the global market size will reach US$ 300 million by 2024, from US$ 210 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Restriction Endonucleases business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Restriction Endonucleases market by product type, application, key manufacturers and key regions and countries.
This study considers the Restriction Endonucleases value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Type I
Type II
Type III
Type IV
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Academic & Research Institutes
Hospitals & Diagnostic Centers
Biopharmaceutical
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
New England Biolabs
Thermo Fisher Scientific
Takara Bio
Illumina
Agilent Technologies
Roche
GE Healthcare
Promega Corporation
Qiagen
Jena Biosciences
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Restriction Endonucleases consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Restriction Endonucleases market by identifying its various subsegments.
Focuses on the key global Restriction Endonucleases manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Restriction Endonucleases with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Restriction Endonucleases submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Restriction Endonucleases Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Restriction Endonucleases Consumption 2014-2024
- 2.1.2 Restriction Endonucleases Consumption CAGR by Region
- 2.2 Restriction Endonucleases Segment by Type
- 2.2.1 Type I
- 2.2.2 Type II
- 2.2.3 Type III
- 2.2.4 Type IV
- 2.2.5 Others
- 2.3 Restriction Endonucleases Consumption by Type
- 2.3.1 Global Restriction Endonucleases Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Restriction Endonucleases Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Restriction Endonucleases Sale Price by Type (2014-2019)
- 2.4 Restriction Endonucleases Segment by Application
- 2.4.1 Academic & Research Institutes
- 2.4.2 Hospitals & Diagnostic Centers
- 2.4.3 Biopharmaceutical
- 2.4.4 Other
- 2.5 Restriction Endonucleases Consumption by Application
- 2.5.1 Global Restriction Endonucleases Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Restriction Endonucleases Value and Market Share by Application (2014-2019)
- 2.5.3 Global Restriction Endonucleases Sale Price by Application (2014-2019)
3 Global Restriction Endonucleases by Players
- 3.1 Global Restriction Endonucleases Sales Market Share by Players
- 3.1.1 Global Restriction Endonucleases Sales by Players (2017-2019)
- 3.1.2 Global Restriction Endonucleases Sales Market Share by Players (2017-2019)
- 3.2 Global Restriction Endonucleases Revenue Market Share by Players
- 3.2.1 Global Restriction Endonucleases Revenue by Players (2017-2019)
- 3.2.2 Global Restriction Endonucleases Revenue Market Share by Players (2017-2019)
- 3.3 Global Restriction Endonucleases Sale Price by Players
- 3.4 Global Restriction Endonucleases Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Restriction Endonucleases Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Restriction Endonucleases Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Restriction Endonucleases by Regions
- 4.1 Restriction Endonucleases by Regions
- 4.1.1 Global Restriction Endonucleases Consumption by Regions
- 4.1.2 Global Restriction Endonucleases Value by Regions
- 4.2 Americas Restriction Endonucleases Consumption Growth
- 4.3 APAC Restriction Endonucleases Consumption Growth
- 4.4 Europe Restriction Endonucleases Consumption Growth
- 4.5 Middle East & Africa Restriction Endonucleases Consumption Growth
5 Americas
- 5.1 Americas Restriction Endonucleases Consumption by Countries
- 5.1.1 Americas Restriction Endonucleases Consumption by Countries (2014-2019)
- 5.1.2 Americas Restriction Endonucleases Value by Countries (2014-2019)
- 5.2 Americas Restriction Endonucleases Consumption by Type
- 5.3 Americas Restriction Endonucleases Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Restriction Endonucleases Consumption by Countries
- 6.1.1 APAC Restriction Endonucleases Consumption by Countries (2014-2019)
- 6.1.2 APAC Restriction Endonucleases Value by Countries (2014-2019)
- 6.2 APAC Restriction Endonucleases Consumption by Type
- 6.3 APAC Restriction Endonucleases Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Restriction Endonucleases by Countries
- 7.1.1 Europe Restriction Endonucleases Consumption by Countries (2014-2019)
- 7.1.2 Europe Restriction Endonucleases Value by Countries (2014-2019)
- 7.2 Europe Restriction Endonucleases Consumption by Type
- 7.3 Europe Restriction Endonucleases Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Restriction Endonucleases by Countries
- 8.1.1 Middle East & Africa Restriction Endonucleases Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Restriction Endonucleases Value by Countries (2014-2019)
- 8.2 Middle East & Africa Restriction Endonucleases Consumption by Type
- 8.3 Middle East & Africa Restriction Endonucleases Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Restriction Endonucleases Distributors
- 10.3 Restriction Endonucleases Customer
11 Global Restriction Endonucleases Market Forecast
- 11.1 Global Restriction Endonucleases Consumption Forecast (2019-2024)
- 11.2 Global Restriction Endonucleases Forecast by Regions
- 11.2.1 Global Restriction Endonucleases Forecast by Regions (2019-2024)
- 11.2.2 Global Restriction Endonucleases Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Restriction Endonucleases Forecast by Type
- 11.8 Global Restriction Endonucleases Forecast by Application
12 Key Players Analysis
- 12.1 New England Biolabs
- 12.1.1 Company Details
- 12.1.2 Restriction Endonucleases Product Offered
- 12.1.3 New England Biolabs Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 New England Biolabs News
- 12.2 Thermo Fisher Scientific
- 12.2.1 Company Details
- 12.2.2 Restriction Endonucleases Product Offered
- 12.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Thermo Fisher Scientific News
- 12.3 Takara Bio
- 12.3.1 Company Details
- 12.3.2 Restriction Endonucleases Product Offered
- 12.3.3 Takara Bio Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Takara Bio News
- 12.4 Illumina
- 12.4.1 Company Details
- 12.4.2 Restriction Endonucleases Product Offered
- 12.4.3 Illumina Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Illumina News
- 12.5 Agilent Technologies
- 12.5.1 Company Details
- 12.5.2 Restriction Endonucleases Product Offered
- 12.5.3 Agilent Technologies Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Agilent Technologies News
- 12.6 Roche
- 12.6.1 Company Details
- 12.6.2 Restriction Endonucleases Product Offered
- 12.6.3 Roche Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Roche News
- 12.7 GE Healthcare
- 12.7.1 Company Details
- 12.7.2 Restriction Endonucleases Product Offered
- 12.7.3 GE Healthcare Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 GE Healthcare News
- 12.8 Promega Corporation
- 12.8.1 Company Details
- 12.8.2 Restriction Endonucleases Product Offered
- 12.8.3 Promega Corporation Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Promega Corporation News
- 12.9 Qiagen
- 12.9.1 Company Details
- 12.9.2 Restriction Endonucleases Product Offered
- 12.9.3 Qiagen Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Qiagen News
- 12.10 Jena Biosciences
- 12.10.1 Company Details
- 12.10.2 Restriction Endonucleases Product Offered
- 12.10.3 Jena Biosciences Restriction Endonucleases Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Jena Biosciences News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Restriction Endonucleases . Industry analysis & Market Report on Restriction Endonucleases is a syndicated market report, published as Global Restriction Endonucleases Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Restriction Endonucleases market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
